October 20, 2014 2:14 PM ET

Pharmaceuticals

Company Overview of Forest Laboratories, Inc.

Executive Profile

Brenton L. Saunders J.D.

Chief Executive Officer, President and Director, Actavis plc
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 10 different industries.

See Board Relationships
44--

Background

Mr. Brenton L. Saunders, also known as Brent, J.D., has been the Chief Executive Officer and President of Actavis plc since July 1, 2014. Mr. Saunders served as Chief Executive Officer and President of Forest Laboratories Inc from October 1, 2013 to 2014. Mr. Saunders served as an Advisor of Valeant Pharmaceuticals International, Inc. since August 2013. He served as Senior Vice President of Compliance, Legal and Regulatory at HomeCare America. Mr. Saunders served as ...

Corporate Headquarters

909 Third Avenue
New York, New York 10022

United States

Phone: 212-421-7850
Fax: --

Board Members Memberships

Director
2010-N/A
Former Chief Executive Officer and Director
2010-N/A
Former Chief Executive Officer and Director
2011-N/A
Former Chief Executive Officer, President, Director, Chairman of Compensation Committee and Member of Compliance Committee
2014-Present
Chief Executive Officer, President and Director

Education

BA
University of Pittsburgh
JD
Temple University School Of Law
MBA
Fox School of Business and Management Temple University in Philadelphia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
José E. Almeida Chairman, Chief Executive Officer and President
Covidien plc
$1.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Forest Laboratories, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.